Bank of Baroda has broken out of a consolidation range with bullish technical indicators, including a weekly bullish engulfing pattern and ...

From a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...

Indian equities extended their recovery amid easing US-Iran tensions and softer crude prices. Analysts recommended Titagarh Rail Systems an...

The conditions that created the worst 18 months for small-caps are starting to ease. The US-Iran war is moving towards settlement. Crude pr...

A peace deal, if it comes, will not mean the Gulf region has become stable. It will only mean that current tensions have been paused. The k...

When it comes to banking, remember this: PSU and private banks have different kinds of loan books; at the end of the day, however, both ope...

The US-Iran peace deal is finally about to happen. There is a high probability that global markets will see a relief rally, a part of which...

Foreign institutional investors have sold Indian stocks worth Rs 5.5 lakh crore. However, a hidden list reveals 84 stocks where FIIs have a...

Indian markets are surging out of a month-long lull, with Nifty poised to reclaim April highs. Rajesh Bhosale of Angel One sees strong posi...

Vedanta’s four demerged entities debuted on exchanges, with brokerages highlighting aluminium as the most attractive segment. Analysts cite...

Stock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...

Over half of India's top Nifty50 stocks are now trading at lower forward P/E multiples than in 2023, indicating a significant valuation cor...

Nifty's strong breakout above 23,500 has turned technical analysts bullish, anticipating a move towards 24,000-24,500. Analysts highlight i...

On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...

Domestic markets recovered modestly on easing oil prices and selective buying in banking and pharma stocks. Analysts have recommended Allie...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Jefferies sees significant growth for Meesho. The brokerage initiated coverage with a 'Buy' rating and a target price of Rs 225. This sugge...